Clinical trial
High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of…
NCT00152685 · University Hospital, Angers, Other · Unknown status
Key facts
| NCT number | NCT00152685 |
|---|---|
| Title | High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury |
| Lead sponsor | University Hospital, Angers, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Severe Head Injury |
| Intervention type | Drug |
| Interventions | human serum albumin |
| Enrollment | 40 |
| First posted | Sep 9, 2005 |
| Last update posted | Dec 1, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: